Skip to content

Biosimilars news

Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.

Success and savings with British Columbia’s biosimilars initiative

Anar Dossa, Director of Pharmacy Services at Pacific Blue Cross, shares the private insurer’s success and savings with biosimilar switching and future plans in this interview with the Not So Different podcast.

Read more

Biosimilars initiative saves precious health dollars in a time of COVID-19

This Pacific Blue Cross op-ed in Business in Vancouver notes that the savings from biosimilars are a welcome influx of resources as COVID-19 continues to exhaust the B.C.’s healthcare system, enabling the Ministry to reallocate money towards other pressing health needs.

Read more

Biosimilar Breakthrough

20Sense Report interview with Dr. Alan Low on the impact of BC’s biosimilar policies.

Read more

Tug of War

Biosimilars have made great strides in Canada but have a lot further to go, as explored in this 20Sense Report article.

Read more

Biosimilars, pharmacogenetics helping to shape the future of pharmacy benefits management

Benefits Canada report on the Face to Face Drug Plan Management Forum held on December 9, 2020.

Read more

A legislative update on provincial biosimilar policies

This Benefits Canada article highlights how private insurers can benefit from aligning with provincial biosimilars policies.

Read more
1 8 9 10 11 12 15